Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Nanoparticles Deliver Hydrogen in Mice After Stroke

Magnesium silicate nanosheets enable sustained hydrogen release to attenuate secondary brain injury following intracerebral hemorrhage

Research hubs: Brain & Nervous System · Cardiovascular System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Magnesium silicate nanosheets enable sustained hydrogen release to attenuate secondary brain injury following intracerebral hemorrhage
Evidence type
Animal study (mouse)
Authors
Chang-Sheng Ma, Bo Han, Jia-Ru Guo, Jin-Fen Guo, Chang-Ku Shi, Yu-Xi Liu, Wen-Jing Yi, Li-Ying Zhang, Ai-Jun Deng, Ying-Shuai Wang, Mao-Tao He
Journal
Journal of Translational Medicine
Year
2026
Study Type
Mouse
Delivery
Gas (Sustained Release)
Dose
orally administered magnesium silicate nanosheets
Outcome
Positive
Peer Reviewed
Yes
Cited by
0 (OpenAlex, as of November 2026)
Country
China

TL;DR

Orally administered magnesium silicate nanosheets provided sustained hydrogen release and reduced secondary brain injury after intracerebral hemorrhage in mice.

Key Finding

Magnesium silicate nanoparticles that slowly release hydrogen gas reduced secondary brain injury (damage that occurs after the initial bleeding) in mice with intracerebral hemorrhage more effectively than conventional hydrogen gas inhalation.

Summary

Researchers tested a new nanoparticle material (made from magnesium silicate) designed to release hydrogen gas slowly in the brain to treat intracerebral hemorrhage, a type of stroke caused by bleeding in the brain. In mice with this type of stroke, the nanoparticles reduced brain swelling, preserved brain cells, and decreased harmful inflammation and cell death better than standard hydrogen gas inhalation.

Practical Takeaway

This is early-stage research in mice only, so it cannot yet be applied to humans. The study suggests that a sustained-release hydrogen delivery method may be more effective than inhaled hydrogen for brain injury, but human clinical trials would be needed to determine if this approach is safe and effective for stroke patients.

Abstract (excerpt)

Background: Intracerebral hemorrhage (ICH) is a devastating stroke subtype with high mortality and disability, primarily driven by secondary brain injury involving oxidative stress, neuroinflammation, and apoptosis. Molecular hydrogen (H₂) exhibits potent neuroprotective effects; however…

Read the full abstract on PubMed